Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
MiraSOFT
- Development stage
- Unknown
- Lead developer
- Bayer
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
MiraSOFT is an over-the-counter, stimulant-free stool softener developed and launched by Bayer. Formulated as easy-to-swallow liquid gels, its active ingredient is docusate sodium (100 mg), which functions as an anionic surfactant to lower the surface tension of stool, allowing water and lipids to penetrate and soften hard, dry feces. Indicated for the relief of occasional constipation, MiraSOFT typically produces a bowel movement within 12 to 72 hours. As of September 2026, the product is available exclusively at CVS Pharmacy locations and CVS.com.
- Brand names
- MiraSOFT
- Other names
- MiraSOFT Stool Softener Liquid Gels
Beyond the preview
Go deeper on MiraSOFT.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on MiraSOFT.